-0.0015 (-2.256%)Mean Reversion
Neutral
Trend
Neutral
Event
Neutral
Mqv
Very Weak
Garp
Very Weak
Mqv Small
Neutral
Value
Consensus
Price
Very Weak
Earnings
Very Strong
Earnings
Very Strong
Dividends
Very Weak
Capital Efficiency
Very Weak
Balance Sheet
Neutral
Website
Shield Therapeutics Plc
Telephone
44.191.511.8500
Address
Studio 6, 3rd Floor, Baltic Business Quarter, Northern Design Centre, Gateshead Quays, Gateshead NE8 3DF
Market Cap
PE
EV/EBITDA
DIV Yield
Franking
Ex Dividend Date (est.)
52 weeks range
Low 0.02 - 0.12
Trade Value (12mth)
US$73,989.00
1 week
-4.41%
1 month
-31.58%
YTD
-34.01%
1 year
165.31%
All time high
1.91
EPS 3 yr Growth
-90.60%
EBITDA Margin
-18.00%
Operating Cashflow
-$9m
Free Cash Flow Return
-42.20%
ROIC
-86.30%
Interest Coverage
-1.20
Quick Ratio
0.70
Shares Outstanding (Fully Diluted)
0m
HALO Sector
Healthcare
Next Company Report Date
29-Apr-27
Next Ex Dividend Date
N/A
Next Dividend Pay Date
N/A
Reporting Currency
USD
Short Sell (% of issue)
0.00
| Date | Announcements |
| 05 May 26 | |
| 01 May 26 | |
| 30 April 26 | |
| 27 April 26 | |
| 09 April 26 |
Historical data
Forecast data
| USD | 2021 | 2022 | 2023 | 2024 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | |||
| Per Share, Growth & Valuations | |||||||||||||
EPS (Basic) | $ |  | | | | -0.05 | -0.03 | -0.02 | | | | ||
EPS (Fully Diluted) | $ | | | | | -0.05 | -0.03 | -0.02 | | | | ||
Growth | % | | | | | 78.4 | 24.6 | 42.4 | | | | ||
PE | X | | | | | N/A | N/A | N/A | | | | ||
EV/EBITDA | X | | | | | N/A | N/A | N/A | | | | ||
Ex Dividend Date (est.)
DIV Yield
Franking Level
DPSg
Quality Yield
Falling Divs over next 2
Consensus Score
Recommendation
EPS 1 month Change
Quality Yield
Falling Divs over next 2
